AllanTenorioMD
Infectious Disease • Durham, NCHIV/AIDS Medicine
VP, Head of Translational Research and HIV Cure, ViiV Healthcare
Dr. Tenorio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Durham
Durham, NC 27701
Education & Training
Rush University Medical CenterFellowship, Infectious Disease, 1998 - 2000- Rush University Medical CenterChief Residency, Internal Medicine, 1997 - 1998
- Rush University Medical CenterResidency, Internal Medicine, 1994 - 1997
University of the Philippines College of MedicineClass of 1993
Certifications & Licensure
IL State Medical License 1996 - 2026- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease Start of enrollment: 2008 Oct 01
- Rifaximin as a Modulator of Microbial Translocation and Immune Activation Start of enrollment: 2011 Sep 01
Publications & Presentations
PubMed
- Inflammatory Biomarker Reduction With Fostemsavir Over 96 Weeks in Heavily Treatment-Experienced Adults With Multidrug-Resistant HIV-1 in the BRIGHTE Study.Andrew Clark, Manyu Prakash, Shiven Chabria, Amy Pierce, Jose R Castillo-Mancilla
Open Forum Infectious Diseases. 2024-09-01 - 6 citationsWeek 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1.Judith A Aberg, Bronagh Shepherd, Marcia Wang, Jose V Madruga, Fernando Mendo Urbina
Infectious Diseases and Therapy. 2023-09-01 - 2 citationsGrowth analysis among adolescents with moderate-to-severe atopic dermatitis receiving upadacitinib in combination with topical corticosteroids in Japan: A case study s...Toshiaki Tanaka, Takuya Sasaki, Kimitoshi Ikeda, Jianzhong Liu, Allan R Tenorio
The World Allergy Organization Journal. 2022-09-01
Professional Memberships
- Member
Other Languages
- Filipino, Tagalog
Industry Relationships
- Director, Clinical Development, ViiV Healthcare2015 - Present
- Director, Clinical Development, GlaxoSmithKline2014 - 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
